SYP and prostate cancer: Despite seven of nine expressed NE genes, the absence of the benchmark NE markers such as chromogranin and SYP begs for further interrogation into the possible NE phenotype of ACRJ-PC28 and validates the need for diverse prostate cancer cell lines.